Despite being a minor contributor to Aβ-binding in the plasma, apoE (especially the apoE4) is considered as one of the major contributors to Aβ clearance in the brain and is the major genetic risk factor for development of late-onset AD (for review see Hauser and Ryan, 2013). This evidence concerns the gene APOE and Alzheimer disease.